XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma? - Wikidata - awgldk - TriplyDB

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

http://www.wikidata.org/entity/Q38115231

about

Vinblastine as a second rescue for the treatment of canine multicentric lymphoma in 39 cases (2005 to 2014).Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children.XI. Management of paediatric and adult non-Hodgkin lymphoma: what lessons can each teach the other?Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study.Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry.Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies.

P2860

Q33432667-8C2A3B74-56B4-48BF-8B59-567DDBA69B79 Q37543840-D92BF1D6-7B63-46B0-AE53-24DDE35E594B Q38389260-39E73C28-3C5E-436E-A4FA-37874F080F6B Q38536238-F1BD11F6-4883-4400-8D8F-C6D6BE5B0702 Q38766227-CD365F49-507F-4652-B827-542D7F1D69F8 Q40912836-BF9695FB-FA4C-4A65-9AC9-DAE1F1203EF2 Q48341313-20676446-2A77-4288-8917-E2A1E5EDEC86 Q53672090-5B70B02C-5F63-4E7A-AF29-501E1A768DEC

P2860

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

http://www.wikidata.org/entity/Q38115231

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

@en

type

label

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

@en

prefLabel

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

@en

P1433

Q38115231-8365B4DC-EAE3-40FF-B45C-DDC9A8F6AF68

P1476

Q38115231-DE26E93A-2D02-4C67-AEB6-7111BB1D3232

P2093

Q38115231-099858D0-5DD3-4431-B1E2-691709D99B72

P2860

Q38115231-06A3E11F-BF8D-406C-9BF9-C5B059F895A0

Q38115231-24F78AC1-8A99-48EF-AC69-E3724453FF53

Q38115231-3AF2A011-0D8C-4A69-8C4E-680CA67F0B7E

Q38115231-41E4877C-2A37-428B-999F-269BF34423C1

Q38115231-633BEBD3-31D6-4B63-AB17-4B594FA03AFA

Q38115231-7F90E054-F875-416B-A192-499AA964AE78

Q38115231-8F6E7536-AA91-4B05-924B-FDB138BC7291

Q38115231-BC47126B-D1B6-4E2C-8155-A5901CD03B8B

Q38115231-C885BD04-3371-4C19-9EFD-681110DA0F0F

Q38115231-CC2DF344-CE11-4AD6-86F2-D0C8D512069C

P304

Q38115231-2F62E1EC-3CC0-49A2-BFB7-7BC267952301

P31

Q38115231-692618B0-6361-4936-A3B7-B6BDE04E94A3

P356

Q38115231-008D206C-9A66-45AF-88D5-A1EAF0C877C4

P478

Q38115231-F6A4CBA2-51FA-489A-8764-056E4A0A72FE

P577

Q38115231-679B005A-5332-451A-BB5E-8A3A23626F0B

P5875

Q38115231-BEF4B5FB-8913-4120-B212-A17F4BF2FB7E

P698

Q38115231-C0694B17-805E-4CAE-8108-E7700CAE5C81

P921

Q38115231-6555F321-8C83-411A-8ADB-F4F66566D2F6

P356

P1433

Hematological Oncology

P1476

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

@en

P2093

Wilhelm Woessmann

http://www.w3.org/2001/XMLSchema#string

P2860

Crizotinib in anaplastic large-cell lymphoma.

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era

Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.

Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia.

The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan.

P304

64-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HON.2069

http://www.w3.org/2001/XMLSchema#string

P478

31 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239940287

http://www.w3.org/2001/XMLSchema#string

P698

23775653

http://www.w3.org/2001/XMLSchema#string

P921